Biomass specific perfusion rate as a control lever for the continuous manufacturing of biosimilar monoclonal antibodies from CHO cell cultures
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index; 9 of the 32 sources its claims cite were checked for support.
Abstract
Continuous manufacturing enables high volumetric productivities of biologics such as monoclonal antibodies. However, it is challenging to maintain both high viable cell densities and productivities at the same time for long culture durations. One of the key controls in a perfusion process is the perfusion rate which determines the nutrient availability and potentially controls the cell metabolism. Cell Specific Perfusion Rate (CSPR) is a feed rate proportional to the viable cell density while Biomass Specific Perfusion Rate (BSPR) is a feed rate proportional to the biomass (cell volume multiply by cell density). In this study, perfusion cultures were run at three BSPRs in the production phase. Low BSPR favored a growth arresting state that led to gradual increase in cell volume, which in turn led to an increase in net perfusion rate proportional to the increase in cell volume. Consequently, at low BSPR, while the cell viability and cell density decreased, high specific productivity of 55 pg per cell per day was achieved. In contrast, the specific productivity was lower in bioreactors operating at a high BSPR. The ability to modulate the cell metabolism by using BSPR was confirmed when the specific productivity increased after lowering the BSPR in one of the bioreactors that was initially operating at a high BSPR. This study demonstrated that BSPR significantly influenced cell growth, metabolism, and productivity in cultures with variable cell volumes.
Overview
CoChat Summary
TL;DR
Biomass specific perfusion rate (BSPR) was tested as a control lever in CHO perfusion cultures producing an omalizumab biosimilar, with low BSPR triggering growth arrest, larger cells, and higher specific productivity. The study concludes that BSPR can modulate cell growth, metabolism, and productivity by accounting for increasing cell volume during production.
Key findings
- Low BSPR (6.5 mL cm⁻³ per day) reduced growth and viability but increased cell diameter from 16.5 µm to 21.7 µm (31.5% increase) by Day 14, while specific productivity reached 55.7 pg cell⁻¹ day⁻¹, three times that at BSPR 12 mL cm⁻³ per day; permeate titer was 2.97 times higher, volumetric productivity 2.5 times higher, and total product mass 1.7 times greater than at BSPR 12.
- Higher BSPR increased lactate and decreased ammonium: final lactate was 0.35 ± 0.09, 0.55 ± 0.07, and 0.73 ± 0.01 g L⁻¹ for BSPR 6.5, 8.0, and 12 mL cm⁻³ per day, respectively; final ammonium was 8.91 ± 0.68, 5.68 ± 0.05, and 4.52 ± 0.18 mM, respectively.
- Lowering BSPR from 12 to 6.5 mL cm⁻³ per day on Day 14 caused a response within 48 h: growth rate dropped from 0.18 to 0.04 per day, cell diameter increased significantly to 19.5 µm (p = 0.038), and Qp was 23.2 ± 3.5 versus 17.6 ± 0.6 pg cell⁻¹ day⁻¹ for unchanged BSPR 12; biomass-specific productivity was not significantly different (7.7 ± 1.0 versus 6.3 ± 0.4 pg cm⁻³ day⁻¹).
- Increasing glucose setpoint from 3 to 6 g L⁻¹ did not significantly improve viable cell density or viability, but increased lactate from 0.32 ± 0.04 to 0.44 ± 0.07 g L⁻¹ and decreased ammonium from 8.9 ± 0.6 to 7.3 ± 0.3 mM.
Methods
- Suspension CHO cells expressing an omalizumab biosimilar were run in parallel Ambr 250 high-throughput perfusion bioreactors at 223 mL working volume, with duplicates and hollow fiber TFF filters; temperature was shifted from 37°C to 34°C when viable cell density exceeded 50 million cells mL⁻¹, and automated bolus bleeding maintained density below 60 million cells mL⁻¹.
- Growth phase used CSPR 0.125 nL cell⁻¹ day⁻¹ up to 2 VVD; production phase used BSPR 6.5, 8.0, or 12 mL cm⁻³ per day. On Days 14 and 20, either glucose setpoint or BSPR was changed in one bioreactor per duplicate set.
- At-line measurements used Bioprofile FLEX2 for cell density, viability, diameter, glucose, lactate, and ammonium; amino acids were measured by UPLC; product quality used Protein A HPLC, SEC, cation exchange, and CE-SDS. Productivity was calculated from product in bioreactor, bleed, and permeate divided by average cell number; two-factor ANOVA with Tukey’s HSD used p < 0.05.
Limitations
- The paper states that reducing ammonium production by supplementing media with lactate or pyruvate was not tested in this study.
- The paper reports n = 1 for the BSPR shift experiment (12 to 6.5 mL cm⁻³ per day) and for the glucose shift experiment (3 to 6 g L⁻¹), limiting statistical strength for those interventions.
- Evident from the text: experiments were performed in 250 mL Ambr 250 mini bioreactors, so scale-up to larger manufacturing bioreactors was not demonstrated; product quality was sampled only on Days 8 and 14.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
8 Valid · 3 Not valid · 15 Not checked · 92 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“However, glucose cannot be completely eliminated because substitution with other sugars such as galactose, fructose, mannose, or maltose has resulted in lower viable cell densities.[18,19]”
§ Biomass specific perfusion rate as a control lever for the continuous manufacturing of biosimilar monoclonal antibodies from CHO cell cultures > INTRODUCTION
What the sources say
- Not checked — no full text of the sourcecites [18] matched to “Mechanisms driving the lactate switch in Chinese hamster ovary cells” (2018) source
- Partly supportedcites [19] matched to “Evaluation and use of disaccharides as energy source in protein-free mammalian cell cultures” (2017) sourceExperimental — accuracy not yet measured
The Results section on CHO-K1 cells adapted to maltose reports a lower maximum viable cell density with maltose than with glucose (1.4 versus 5.9 million cells/ml). But it also reports that the cells grew with no detectable glucose in the medium, contrary to the claim that glucose cannot be completely eliminated. The passages do not establish the stated density comparison for galactose, fructose, or mannose. (LLM, conf=0.88)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“One of the critical process parameters is the culture media perfusion rate.[2]”
§ Biomass specific perfusion rate as a control lever for the continuous manufacturing of biosimilar monoclonal antibodies from CHO cell cultures > INTRODUCTION
What the sources say
- Supportedcites [2] matched to “Recommendations for Comparison of Productivity Between Fed‐Batch and Perfusion Processes” (2019) source
The Experimental Section identifies the perfusion rate as a key variable of perfusion processes and describes it as the continuous supply of fresh medium. It also discusses controlling that rate to provide an appropriate medium supply per cell, supporting the claim that it is a critical process parameter. (LLM, conf=0.90)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The ability to modulate the cell metabolism by using BSPR was confirmed when the specific productivity increased after lowering the BSPR in one of the bioreactors that was initially operating at a high BSPR.”
§ Biomass specific perfusion rate as a control lever for the continuous manufacturing of biosimilar monoclonal antibodies from CHO cell cultures > Abstract
plainstates a causeSingle case- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In contrast, the specific productivity was lower in bioreactors operating at a high BSPR.”
§ Biomass specific perfusion rate as a control lever for the continuous manufacturing of biosimilar monoclonal antibodies from CHO cell cultures > Abstract
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The average specific cell growth rate for BSPR 6.5 mL cm -3 per day from Days 8 to 14 was -0.05 per day, suggesting that there was little to no cell growth.”
§ Biomass specific perfusion rate as a control lever for the continuous manufacturing of biosimilar monoclonal antibodies from CHO cell cultures > 3.2 Low BSPR reduced overall cell growth rates
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
57 more claims
Create a free account to see all 118 claims and every source verdict.
- Probably not a substantial claim. 26
- It may state two separate claims as one. 37
Citations
Cites
Classifying Ecological Quality and Integrity of Estuaries
Borja, Á., Basset, A., Bricker, S. B., Dauvin, J., Elliott, M., Harrison, T. D., Marques, J. C., Weisberg, S. B., & West, R. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-374711-2.00109-1 · Cited by 2,494
Perfusion mammalian cell culture for recombinant protein manufacturing – A critical review
Bielser, J.-M., Wolf, M., Souquet, J., Broly, H., & Morbidelli, M. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.04.011 · Cited by 263
Altamirano, C., Paredes, C., Cairó, J. J., & Gòdia, F. (2000) · Biotechnology Progress · doi:10.1021/bp990124j · Cited by 197
Considerations on the lactate consumption by CHO cells in the presence of galactose
Altamirano, C., Illanes, A., Becerra, S., Cairó, J. J., & Gòdia, F. (2006) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2006.03.023 · Cited by 182
Gagnon, M., Hiller, G., Luan, Y., Kittredge, A., DeFelice, J., & Drapeau, D. (2011) · Biotechnology and Bioengineering · doi:10.1002/bit.23072 · Cited by 181
Multivariate analysis of cell culture bioprocess data—Lactate consumption as process indicator
Le, H., Kabbur, S., Pollastrini, L., Sun, Z., Mills, K., Johnson, K., Karypis, G., & Hu, W.-S. (2012) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2012.08.021 · Cited by 177
Feeding lactate for CHO cell culture processes: Impact on culture metabolism and performance
Li, J., Wong, C. L., Vijayasankaran, N., Hudson, T., & Amanullah, A. (2012) · Biotechnology and Bioengineering · doi:10.1002/bit.24389 · Cited by 137 · cited 2×
“[15,25] The increase in cell volume could have implications in the consumption rate of nutrients per cell.”
Metabolic characterization of a CHO cell size increase phase in fed-batch cultures
Pan, X., Dalm, C., Wijffels, R. H., & Martens, D. E. (2017) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-017-8531-y · Cited by 135 · cited 2×
“[14,22,23] Furthermore, the increase in cell volume was due to enhancement of transcription, translational, and secretion machinery which led to the increase in productivity.”
The “Push-to-Low” Approach for Optimization of High-Density Perfusion Cultures of Animal Cells
Konstantinov, K., Goudar, C. T., Ng, M. R. A. V., Meneses, R., Thrift, J., Chuppa, S., Matanguihan, C., Michaels, J., & Naveh, D. (2006) · Advances in biochemical engineering, biotechnology · doi:10.1007/10_016 · Cited by 120
Metabolic responses of CHO cells to limitation of key amino acids
Duarte, T. M., Carinhas, N., Barreiro, L. C., Carrondo, M. J. T., Alves, P. M., & Teixeira, A. P. (2014) · Biotechnology and Bioengineering · doi:10.1002/bit.25266 · Cited by 110
Mechanisms driving the lactate switch in Chinese hamster ovary cells
Hartley, F., Walker, T., Chung, V., & Morten, K. (2018) · Biotechnology and Bioengineering · doi:10.1002/bit.26603 · Cited by 108 · cited 2×
“18] Various studies suggested that controlling the glucose concentrations to a low level directs cells to utilize glucose more efficiently.”
Buchsteiner, M., Quek, L., Gray, P. P., & Nielsen, L. K. (2018) · Biotechnology and Bioengineering · doi:10.1002/bit.26724 · Cited by 107
Relationship between cell size, cell cycle and specific recombinant protein productivity
Lloyd, D. R., Holmes, P., Jackson, L. P., Emery, A. N., & Al-Rubeai, M. (2000) · Cytotechnology · doi:10.1023/a:1008103730027 · Cited by 93 · cited 1×
“[14,22,23] Furthermore, the increase in cell volume was due to enhancement of transcription, translational, and secretion machinery which led to the increase in productivity.”
Walther, J., Lu, J., Hollenbach, M., Yu, M., Hwang, C., McLarty, J., & Brower, K. (2019) · Biotechnology Journal · doi:10.1002/biot.201700733 · Cited by 93
Multiplicity of Steady States in Glycolysis and Shift of Metabolic State in Cultured Mammalian Cells
Mulukutla, B. C., Yongky, A., Grimm, S., Daoutidis, P., & Hu, W.-S. (2015) · PLOS ONE · doi:10.1371/journal.pone.0121561 · Cited by 81
Recommendations for Comparison of Productivity Between Fed‐Batch and Perfusion Processes
Bausch, M., Schultheiss, C., & Sieck, J. B. (2019) · Biotechnology Journal · doi:10.1002/biot.201700721 · Cited by 73 · cited 2×
“[2] This rate of culture media entering and exiting the bioreactor can be expressed in vessel volumes per day (vvd − 1 or VVD) and determines nutrient availability.”
Mahal, H., Branton, H., & Farid, S. S. (2021) · Biotechnology and Bioengineering · doi:10.1002/bit.27774 · Cited by 71
Altamirano, C., Cairó, J. J., & Gòdia, F. (2001) · Biotechnology and Bioengineering · doi:10.1002/bit.10096 · Cited by 70
Selection of chemically defined media for CHO cell fed-batch culture processes
Pan, X., Streefland, M., Dalm, C., Wijffels, R. H., & Martens, D. E. (2017) · Cytotechnology · doi:10.1007/s10616-016-0036-5 · Cited by 70 · cited 3×
“[12] Therefore, the precision of pro-cesscontrolsmightbeimprovedwhentheincreasingcellvolumeisalso considered.”
InfluentialHong, J. K., Lee, S. M., Kim, K.-Y., & Lee, G. M. (2014) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-014-5596-8 · Cited by 46
Evaluation and use of disaccharides as energy source in protein-free mammalian cell cultures
Leong, D. S. Z., Tan, J. G. L., Chin, C. L., Mak, S. Y., Ho, Y. S., & Ng, S. K. (2017) · Scientific Reports · doi:10.1038/srep45216 · Cited by 45 · cited 1×
“[18,19] An additional feed line with concentrated glucose allows the glucose setpoint concentration to be controlled independently of the other nutrient concentrations supplied by the perfusion media.”
Self-citationContinuous integrated manufacturing for biopharmaceuticals: A new paradigm or an empty promise?
Rathore, A. S., Thakur, G., & Kateja, N. (2023) · Biotechnology and Bioengineering · doi:10.1002/bit.28235 · Cited by 41
Detailed understanding of enhanced specific antibody productivity in NS0 myeloma cells
Khoo, S. H. G., & Al‐Rubeai, M. (2009) · Biotechnology and Bioengineering · doi:10.1002/bit.22041 · Cited by 38
Improving an intensified and integrated continuous bioprocess platform for biologics manufacturing
Zhou, H., Fang, M., Zheng, X., et al. (2021) · Biotechnology and Bioengineering · doi:10.1002/bit.27768 · Cited by 36
Schulze, M., Lemke, J., Pollard, D., Wijffels, R. H., Matuszczyk, J., & Martens, D. E. (2021) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2021.06.011 · Cited by 34 · cited 1×
“[2,10] The optimal CSPR is dependent on the media formulation and cell line.”
A two-step procedure for the design of perfusion bioreactors
Wolf, M. K. F., Pechlaner, A., Lorenz, V., Karst, D. J., Souquet, J., Broly, H., & Morbidelli, M. (2019) · Biochemical Engineering Journal · doi:10.1016/j.bej.2019.107295 · Cited by 32 · cited 1×
“[11] This maximizes the medium utilization and lowers the cost of production.”
Kim, T. K., Chung, J. Y., Sung, Y. H., & Lee, G. M. (2001) · Biotechnology and Bioprocess Engineering · doi:10.1007/bf02933001 · Cited by 28 · cited 1×
“[14,22,23] Furthermore, the increase in cell volume was due to enhancement of transcription, translational, and secretion machinery which led to the increase in productivity.”
Transcriptome Analysis of CHO Cell Size Increase During a Fed-Batch Process
Pan, X., Alsayyari, A. A., Dalm, C., Hageman, J. A., Wijffels, R. H., & Martens, D. E. (2019) · Biotechnology Journal · doi:10.1002/biot.201800156 · Cited by 22 · cited 2×
“[13,24] The effectiveness of the low BSPR of 6.5 mL cm − 3 per day to trigger growth arrest was reproduced in a bioreactor that had an original BSPR of 12 mL cm − 3 per day.”
InfluentialGowtham, Y. K., Saski, C. A., & Harcum, S. W. (2017) · Biotechnology Progress · doi:10.1002/btpr.2462 · Cited by 16
Repurposing fed‐batch media and feeds for highly productive CHO perfusion processes
Kuiper, M., Spencer, C., Fäldt, E., Vuillemez, A., Holmes, W., Samuelsson, T., Gruber, D., & Castan, A. (2019) · Biotechnology Progress · doi:10.1002/btpr.2821 · Cited by 15
Effects of pyruvate on primary metabolism and product quality for a high‐density perfusion process
Caso, S., Aeby, M., Jordan, M., Guillot, R., & Bielser, J. (2022) · Biotechnology and Bioengineering · doi:10.1002/bit.28033 · Cited by 9 · cited 4×
“[15] In the paper by Caso et al., the authorsdemonstratedacontrolstrategybymaintainingatargetviable cell volume.”
InfluentialRecent advances in continuous downstream processing of antibodies and related products
Kavara, A., Sokolowski, D., Collins, M. J., & Schofield, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-08-103019-6.00004-7 · Cited by 7
Cited by
Hybrid modeling for in silico optimization of a dynamic perfusion cell culture process
Agarwal, P., McCready, C., Ng, S. K., Ng, J. C., van de Laar, J., Pennings, M., & Zijlstra, G. (2025) · Biotechnology Progress · doi:10.1002/btpr.3503 · Cited by 14
Self-citationMalinov, N. G., Barodiya, S., Ierapetritou, M., & Papoutsakis, E. T. (2026) · Biotechnology and Bioengineering · doi:10.1002/bit.70190 · Cited by 5
“Moreover, other studies have chosen to characterize and control their perfusion processes based on the biomass‐specific perfusion rate (BSPR), defined as the volume of media consumed per volume of biomass (Leong et al. 2024).”
Chinakarapong, M., Kotemul, K., Hanprathet, S., Thu, M. M., Pata, S., Laopajon, W., Kasinrerk, W., & Takheaw, N. (2025) · Biotechnology Journal · doi:10.1002/biot.70129 · Cited by 1
Malinov, N. G., Barodiya, S., Ierapetritou, M., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.27.691016 · Cited by 1
Gough, I. A., Corbett, B., Raycraft, J., et al. (2025) · Computers & Chemical Engineering · doi:10.1016/j.compchemeng.2025.109386
Metadata
- Authors
- Leong, J., Tang, W. Q., Chng, J., Ler, W. X., Manan, N. A., Sim, L. C., Zheng, Z. Y., Zhang, W., Walsh, I., Zijlstra, G., Pennings, M., & Ng, S. K.
- Affiliations
- Agency for Science, Technology and Research (SG)
- BiosanaProcess Pte. Ltd. Singapore Republic of Singapore
- Sartorius Stedim Netherlands B.V. Rotterdam The Netherlands
- BiosanaPharma Leiden The Netherlands
- Corresponding author
- Pennings, Maarten
- Ng, Say Kong
- Venue
- Biotechnology Journal
- Publisher
- Wiley
- Published
- 2024-07
- Volume
- 19
- Issue
- 7
- Pages
- e2400092-e2400092
- ISSN
- 1860-6768 (ISSN-L)
- 1860-7314
- OpenAlex
- W4400572166
- Semantic Scholar
- 5abef19da1ed516238766c73ec57702c10f37cc9
- Cited by
- 9
- References
- 32
- Citations by year
- 2026: 6 · 2025: 2 · 2024: 1
- FWCI
- 1.04
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Biotechnology Journal (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Agency for Science, Technology and Research (I1901E0047)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein purification and stability
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Keywords
- CHO cell culture, monoclonal antibody production, biosimilars, cell-specific productivity, viable cell density, cell volume, growth arrest, feed rate control, bioreactor control
- MeSH terms
- Animals, Antibodies, Monoclonal, Cell Count, Cell Survival, Cricetulus, Perfusion, CHO Cells, Biomass, Cell Culture Techniques, Bioreactors, Cell Proliferation, Biosimilar Pharmaceuticals
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.